OBJECTIVE: Peripheral microvascular function is altered in preeclampsia (PE). Recent studies suggest that maternal physiology varies with fetal sex. We wanted to examine if there were sex-specific differences in maternal peripheral microvascular function in normal pregnancy and pregnancy complicated by PE. METHODS: Peripheral microvascular responses were examined using the noninvasive technique of laser Doppler flowmetry in normotensive healthy pregnant women and in women diagnosed with PE. We measured baseline perfusion, response to thermal hyperemia, post-occlusive reperfusion, and vasodilatation in response to corticotropin-releasing hormone (CRH), a potent vasodilator in human skin. RESULTS: At 31 to 40 weeks' gestation those women with a male fetus exhibited increased vasodilatation in response to CRH (P <.05) and greater baseline perfusion (P <.05) than those pregnant with a female fetus. PE women pregnant with a male fetus demonstrated a significantly reduced vasodilatation in response to CRH (P <.05), reduced baseline perfusion (P <.05), and reduced response to thermal hyperemia (P <.05) compared to normotensive women pregnant with a male fetus. Microvascular function was not significantly different between preeclamptic and normotensive women with a female fetus. CONCLUSION: These data show that there are differences in maternal peripheral microvascular function in relation to fetal sex.
OBJECTIVE: Peripheral microvascular function is altered in preeclampsia (PE). Recent studies suggest that maternal physiology varies with fetal sex. We wanted to examine if there were sex-specific differences in maternal peripheral microvascular function in normal pregnancy and pregnancy complicated by PE. METHODS: Peripheral microvascular responses were examined using the noninvasive technique of laser Doppler flowmetry in normotensive healthy pregnant women and in women diagnosed with PE. We measured baseline perfusion, response to thermal hyperemia, post-occlusive reperfusion, and vasodilatation in response to corticotropin-releasing hormone (CRH), a potent vasodilator in human skin. RESULTS: At 31 to 40 weeks' gestation those women with a male fetus exhibited increased vasodilatation in response to CRH (P <.05) and greater baseline perfusion (P <.05) than those pregnant with a female fetus. PE women pregnant with a male fetus demonstrated a significantly reduced vasodilatation in response to CRH (P <.05), reduced baseline perfusion (P <.05), and reduced response to thermal hyperemia (P <.05) compared to normotensive women pregnant with a male fetus. Microvascular function was not significantly different between preeclamptic and normotensive women with a female fetus. CONCLUSION: These data show that there are differences in maternal peripheral microvascular function in relation to fetal sex.
Authors: Aida Hanum Ghulam Rasool; Aisyah Syairah Abdul Rahman; Nor Aliza Abd Ghaffar; Nik Mohd Zaki Nik Mahmood; Abd Rahim Wong Journal: Malays J Med Sci Date: 2010-10
Authors: Nándor Gábor Than; Máté Posta; Dániel Györffy; László Orosz; Gergő Orosz; Simona W Rossi; Géza Ambrus-Aikelin; András Szilágyi; Sándor Nagy; Petronella Hupuczi; Olga Török; Adi L Tarca; Offer Erez; Zoltán Papp; Roberto Romero Journal: Placenta Date: 2022-03-22 Impact factor: 3.287
Authors: Francesmary Modugno; Zhuxuan Fu; Susan J Jordan; Aocs Group; Jenny Chang-Claude; Renée T Fortner; Marc T Goodman; Kirsten B Moysich; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Bo Qin; Rebecca Sutphen; John R McLaughlin; Usha Menon; Susan J Ramus; Simon A Gayther; Aleksandra Gentry-Maharaj; Chloe Karpinskyj; Celeste L Pearce; Anna H Wu; Harvey A Risch; Penelope M Webb Journal: Eur J Epidemiol Date: 2020-09-21 Impact factor: 8.082
Authors: Kathleen E O'Neill; Methodius Tuuli; Anthony O Odibo; Randall R Odem; Amber Cooper Journal: Fertil Steril Date: 2013-11-09 Impact factor: 7.329
Authors: E Colicino; W Cowell; A Bozack; N Foppa Pedretti; A Joshi; M M Niedzwiecki; V Bollati; C Berin; R O Wright; R J Wright Journal: Environ Res Date: 2020-08-22 Impact factor: 6.498
Authors: Elizabeth Ann L Enninga; Wendy K Nevala; Douglas J Creedon; Svetomir N Markovic; Shernan G Holtan Journal: Am J Reprod Immunol Date: 2014-08-04 Impact factor: 3.886